ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
May 20, 2024 06:50 ET
|
ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., May 20, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Kionex® (Sodium Polystyrene Sulfonate Suspension USP)...
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints
May 20, 2024 06:30 ET
|
Dyne Therapeutics, Inc.
- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months - - DYNE-101 Showed Improvement in Myotonia,...
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
May 20, 2024 06:30 ET
|
Bionomics Ltd
ADELAIDE, Australia and CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel,...
Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia
May 20, 2024 06:00 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., May 20, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) and Otsuka Pharmaceutical Co., Ltd (Otsuka) announced today that the primary endpoint was achieved in the Phase 3 trial in...
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
May 20, 2024 06:00 ET
|
MediciNova, Inc.
LA JOLLA, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange...
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
May 20, 2024 06:00 ET
|
Fractyl Health, Inc.
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
BitFuFu Inc. Reports Unaudited First Quarter 2024 Financial Results
May 20, 2024 05:30 ET
|
Bitfufu Inc.
SINGAPORE, May 20, 2024 (GLOBE NEWSWIRE) -- BitFuFu Inc., (“BitFuFu” or “the Company”) (NASDAQ: FUFU), a fast-growing digital asset mining service and world-leading cloud-mining service provider,...
VEON’s Banglalink and Robi Axiata Partner to Explore Network Sharing to Expand 4G Access in Bangladesh
May 20, 2024 05:01 ET
|
VEON Ltd.
Amsterdam and Dhaka, 20 May 2024: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that Banglalink, its...
Li Auto Inc. Announces Unaudited First Quarter 2024 Financial Results
May 20, 2024 04:30 ET
|
Li Auto Inc.
Quarterly total revenues reached RMB25.6 billion (US$3.6 billion)1Quarterly deliveries reached 80,400 vehicles BEIJING, China, May 20, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the...
Himax Technologies, Inc. to Attend Baird 2024 Global Consumer, Technology and Services Conference on June 4 – June 6, 2024
May 20, 2024 04:00 ET
|
Himax Technologies, Inc.
TAINAN, Taiwan, May 20, 2024 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other...